메뉴 건너뛰기




Volumn 526, Issue 2, 2012, Pages 124-131

Anti-bacterial monoclonal antibodies: Back to the future?

Author keywords

Anti infective monoclonal antibodies; Antibody combinations and cocktails; Companion diagnostics; mAb engineering; Multi drug resistant bacterial pathogens; Translational medicine

Indexed keywords

ANTIINFECTIVE AGENT; AUROGRAB; CENTOXIN; EDOBACOMAB; ESCHERICHIA COLI ENDOTOXIN; ETI 204; LIPOTEICHOIC ACID; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; PAGIBAXIMAB; PANOBACUMAB; RAXIBACUMAB; TEFIBAZUMAB; UNCLASSIFIED DRUG; VANCOMYCIN;

EID: 84865690747     PISSN: 00039861     EISSN: 10960384     Source Type: Journal    
DOI: 10.1016/j.abb.2012.06.001     Document Type: Review
Times cited : (64)

References (108)
  • 12
    • 40949099893 scopus 로고    scopus 로고
    • A.J. O'Neill Drugs 17 2008 297 302
    • (2008) Drugs , vol.17 , pp. 297-302
    • O'Neill, A.J.1
  • 19
    • 0036877034 scopus 로고    scopus 로고
    • I. Ginsburg APMIS 110 2002 753 770
    • (2002) APMIS , vol.110 , pp. 753-770
    • Ginsburg, I.1
  • 23
    • 3242798175 scopus 로고    scopus 로고
    • J.D. Marks Mov Disord. 19 Suppl 8 2004 S101 S108
    • (2004) Mov Disord. , vol.19 , Issue.SUPPL. 8
    • Marks, J.D.1
  • 83
    • 84865687468 scopus 로고    scopus 로고
    • Anon, U. S. Department of Health and Human Services, Food and Drug Administration. (2010).
    • Anon, U. S. Department of Health and Human Services, Food and Drug Administration. (2010).


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.